First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies

Clinical trial NCT05348889 · TERMINATED

Trial details

NCT number: NCT05348889
Sponsor: Chimagen Biosciences, Ltd
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma (disorder)Acute Lymphoid Leukemia, Disease (disorder)

Start date: 2022-08-30
Primary completion: 2024-10-31
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.